Abstract
Background:
The relationship between central obesity and survival in community-dwelling adults with normal body mass index (BMI) is not well-known.
Objective:
To examine total and cardiovascular mortality risks associated with central obesity and normal BMI.
Design:
Stratified multistage probability design.
Setting:
NHANES III (Third National Health and Nutrition Examination Survey).
Participants:
15 184 adults (52.3% women) aged 18 to 90 years.
Measurements:
Multivariable Cox proportional hazards models were used to evaluate the relationship of obesity patterns defined by BMI and waist-to-hip ratio (WHR) and total and cardiovascular mortality risk after adjustment for confounding factors.
Results:
Persons with normal-weight central obesity had the worst long-term survival. For example, a man with a normal BMI (22 kg/m2) and central obesity had greater total mortality risk than one with similar BMI but no central obesity (hazard ratio [HR], 1.87 [95% CI, 1.53 to 2.29]), and this man had twice the mortality risk of participants who were overweight or obese according to BMI only (HR, 2.24 [CI, 1.52 to 3.32] and 2.42 [CI, 1.30 to 4.53], respectively). Women with normal-weight central obesity also had a higher mortality risk than those with similar BMI but no central obesity (HR, 1.48 [CI, 1.35 to 1.62]) and those who were obese according to BMI only (HR, 1.32 [CI, 1.15 to 1.51]). Expected survival estimates were consistently lower for those with central obesity when age and BMI were controlled for.
Limitations:
Body fat distribution was assessed based on anthropometric indicators alone. Information on comorbidities was collected by self-report.
Conclusion:
Normal-weight central obesity defined by WHR is associated with higher mortality than BMI-defined obesity, particularly in the absence of central fat distribution.
Primary Funding Source:
National Institutes of Health, American Heart Association, European Regional Development Fund, and Czech Ministry of Health.
References
- 1.
Whitlock G ,Lewington S ,Sherliker P ,Clarke R ,Emberson J ,Halsey J ,et al ;Prospective Studies Collaboration . Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-96. [PMID: 19299006] CrossrefMedlineGoogle Scholar - 2.
Cerhan JR ,Moore SC ,Jacobs EJ ,Kitahara CM ,Rosenberg PS ,Adami HO ,et al . A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc. 2014;89:335-45. [PMID: 24582192] CrossrefMedlineGoogle Scholar - 3.
Kahn HS ,Bullard KM ,Barker LE ,Imperatore G . Differences between adiposity indicators for predicting all-cause mortality in a representative sample of United States non-elderly adults. PLoS One. 2012;7:e50428. [PMID: 23226283] CrossrefMedlineGoogle Scholar - 4.
Flegal KM ,Kit BK ,Orpana H ,Graubard BI . Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309:71-82. [PMID: 23280227] CrossrefMedlineGoogle Scholar - 5.
Welborn TA ,Dhaliwal SS . Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr. 2007;61:1373-9. [PMID: 17299478] CrossrefMedlineGoogle Scholar - 6.
Wormser D ,Kaptoge S ,DiAngelantonio E ,Wood AM ,Pennells L ,Thompson A ,et al ;Emerging Risk Factors Collaboration . Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377:1085-95. [PMID: 21397319] CrossrefMedlineGoogle Scholar - 7.
Reis JP ,Macera CA ,Araneta MR ,Lindsay SP ,Marshall SJ ,Wingard DL . Comparison of overall obesity and body fat distribution in predicting risk of mortality. Obesity (Silver Spring). 2009;17:1232-9. [PMID: 19197258] CrossrefMedlineGoogle Scholar - 8.
Flegal KM ,Graubard BI . Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr. 2009;89:1213-9. [PMID: 19190072] CrossrefMedlineGoogle Scholar - 9.
Jensen MD ,Ryan DH ,Apovian CM ,Ard JD ,Comuzzie AG ,Donato KA ,et al ;American College of Cardiology/American Heart Association Task Force on Practice Guidelines . 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129:S102-38. [PMID: 24222017] CrossrefMedlineGoogle Scholar - 10.
Ashwell M ,Mayhew L ,Richardson J ,Rickayzen B . Waist-to-height ratio is more predictive of years of life lost than body mass index. PLoS One. 2014;9:e103483. [PMID: 25198730] CrossrefMedlineGoogle Scholar - 11.
Cornier MA ,Després JP ,Davis N ,Grossniklaus DA ,Klein S ,Lamarche B ,et al ;American Heart Association Obesity Committee of the Council on Nutrition . Assessing adiposity: a scientific statement from the American Heart Association. Circulation. 2011;124:1996-2019. [PMID: 21947291] CrossrefMedlineGoogle Scholar - 12.
Coutinho T ,Goel K ,Corrêa de Sá D ,Carter RE ,Hodge DO ,Kragelund C ,et al . Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of “normal weight central obesity”. J Am Coll Cardiol. 2013;61:553-60. [PMID: 23369419] CrossrefMedlineGoogle Scholar - 13.
Romero-Corral A ,Somers VK ,Sierra-Johnson J ,Korenfeld Y ,Boarin S ,Korinek J ,et al . Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2010;31:737-46. [PMID: 19933515] CrossrefMedlineGoogle Scholar - 14.
Okorodudu DO ,Jumean MF ,Montori VM ,Romero-Corral A ,Somers VK ,Erwin PJ ,et al . Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond). 2010;34:791-9. [PMID: 20125098] CrossrefMedlineGoogle Scholar - 15.
Chowdhury B ,Lantz H ,Sjostrom L . Computed tomography-determined body composition in relation to cardiovascular risk factors in Indian and matched Swedish males. Metabolism. 1996;45:634-44. [PMID: 8622609] CrossrefMedlineGoogle Scholar - 16.
Seidell JC ,Björntorp P ,Sjöström L ,Sannerstedt R ,Krotkiewski M ,Kvist H . Regional distribution of muscle and fat mass in men—new insight into the risk of abdominal obesity using computed tomography. Int J Obes. 1989;13:289-303. [PMID: 2767882] MedlineGoogle Scholar - 17.
Manolopoulos KN ,Karpe F ,Frayn KN . Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond). 2010;34:949-59. [PMID: 20065965] CrossrefMedlineGoogle Scholar - 18. National Center for Health Statistics. National Health and Nutrition Examination Survey. Atlanta, GA: National Center for Health Statistics; 2015. Accessed at www.cdc.gov/nchs/about/major/nhanes/NHANESIII_Reference_Manuals.htm on 1 July 2014. Google Scholar
- 19. National Center for Health Statistics; Office of Analysis and Epidemiology. The Third National Health and Nutrition Examination Survey (NHANES III) linked mortality file: mortality follow-up through 2006: matching methodology. Hyattsville, MD: National Center for Health Statistics; 2009. Accessed at www.cdc.gov/nchs/data/datalinkage/matching_methodology_nhanes3_final.pdf on 1 July 2014. Google Scholar
- 20.
Klein JP ,Moeschberger ML . Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer-Verlag; 2003. Google Scholar - 21.
Makuch RW . Adjusted survival curve estimation using covariates. J Chronic Dis. 1982;35:437-43. [PMID: 7042727] CrossrefMedlineGoogle Scholar - 22.
Yusuf S ,Hawken S ,Ounpuu S ,Bautista L ,Franzosi MG ,Commerford P ,et al ;INTERHEART Study Investigators . Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640-9. [PMID: 16271645] CrossrefMedlineGoogle Scholar - 23.
Van Gaal LF ,Mertens IL ,De Block CE . Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-80. [PMID: 17167476] CrossrefMedlineGoogle Scholar - 24.
Grundy SM . Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89:2595-600. [PMID: 15181029] CrossrefMedlineGoogle Scholar - 25.
Navab M ,Anantharamaiah GM ,Fogelman AM . The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med. 2005;15:158-61. [PMID: 16099381] CrossrefMedlineGoogle Scholar - 26.
Després JP . Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. J Endocrinol Invest. 2006;29:77-82. [PMID: 16751711] MedlineGoogle Scholar
Author, Article, and Disclosure Information
Karine R. Sahakyan,
From the Mayo Clinic, Rochester, Minnesota; St. Anne's University Hospital Brno, Brno, Czech Republic; and University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Grant Support: By the National Institutes of Health (grant HL00711-36; Dr. Sahakyan), American Heart Association (grant 11SDG7260046; Dr. Singh), European Regional Development Fund (Project FNUSA-ICRC [grant CZ.1.05/1.1.00/02.0123; Drs. Somers, Sochor, Singh, and Lopez-Jimenez]), and Czech Ministry of Health (grant NT13434-4/2012; Dr. Sochor).
Disclosures: Dr. Somers reports grants from the National Institutes of Health and Philips Respironics (to the Mayo Foundation for the study of sleep and cardiovascular disease); personal fees from Respicardia, ResMed, Sorin Group, Philips Respironics, GlaxoSmithKline, U-Health (China; www.ttdoc.cn), and Ronda Grey; and other compensation for work with Mayo Health Solutions and their industry partners on intellectual property related to sleep and cardiovascular disease, outside the submitted work. Dr. Sochor's institution, St. Anne's Hospital, was supported by the European Regional Development Fund (Project FNUSA-ICRC [grant CZ.1.05/1.1.00/02.0123]); further, Dr. Sochor was awarded grants from the Ministry of Health of the Czech Republic and SCOPES (NT13434-4/2012 and IZ73Z0_152616, respectively). Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-2525.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer.
Reproducible Research Statement:Study protocol: Available at ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/nhanes/nhanes3/1A/ADULT-acc.pdf. Statistical code and data: Available at www.cdc.gov/nchs/nhanes/nh3data.htm.
Corresponding Author: Francisco Lopez-Jimenez, MD, MS, Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905; e-mail, lopez@mayo.
Current Author Addresses: Drs. Sahakyan, Somers, Rodriguez-Escudero, Sochor, Roger, Singh, and Lopez-Jimenez: Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905.
Mr. Hodge and Dr. Carter: Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905.
Dr. Coutinho: University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario K1Y 4W7, Canada.
Dr. Jensen: Division of Endocrinology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905.
Author Contributions: Conception and design: K.R. Sahakyan, J.P. Rodriguez-Escudero, R.E. Carter, T. Coutinho, F. Lopez-Jimenez.
Analysis and interpretation of the data: K.R. Sahakyan, V.K. Somers, D.O. Hodge, R.E. Carter, O. Sochor, T. Coutinho, M.D. Jensen, V.L. Roger, P. Singh, F. Lopez-Jimenez.
Drafting of the article: K.R. Sahakyan, V.K. Somers, J.P. Rodriguez-Escudero, R.E. Carter, P. Singh, F. Lopez-Jimenez.
Critical revision of the article for important intellectual content: K.R. Sahakyan, V.K. Somers, J.P. Rodriguez-Escudero, D.O. Hodge, R.E. Carter, O. Sochor, T. Coutinho, M.D. Jensen, V.L. Roger, P. Singh, F. Lopez-Jimenez.
Final approval of the article: K.R. Sahakyan, V.K. Somers, J.P. Rodriguez-Escudero, R.E. Carter, T. Coutinho, M.D. Jensen, P. Singh, F. Lopez-Jimenez.
Provision of study materials or patients: F. Lopez-Jimenez.
Statistical expertise: D.O. Hodge, R.E. Carter, F. Lopez-Jimenez.
Obtaining of funding: V.L. Roger.
Administrative, technical, or logistic support: V.K. Somers, P. Singh, F. Lopez-Jimenez.
Collection and assembly of data: R.E. Carter.
This article was published online first at www.annals.org on 10 November 2015.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
*All comments submitted after October 1, 2021 and selected for publication will be published online only.